Possible pathophysiologic mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotensin-converting enzyme inhibitors: clinical and experimental evidence-Reference-Cited by-同舟云学术

Possible pathophysiologic mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotensin-converting enzyme inhibitors: clinical and experimental evidence

Published:2005-07-28 Issue:12 Volume:19 Page:923-931
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Chrysant S G

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/1001916.pdf

Reference71 articles.

1. Chobanian AV et al. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC-7). Hypertension 2003; 42: 1206–1252.

2. Lewington S et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data from one million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet 2002; 360: 1903–1913.

3. Murray CJL, Lopez AD . Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269–1276.

4. Murray CJL, Lopez AD . Global mortality, disability and the contribution of risk factors: global burden of disease study. Lancet 1997; 349: 1436–1442.

5. Goldstein LB et al. Primary prevention of ischemic stroke. A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001; 103: 163–182.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PECULIARITIES OF EARLY DIAGNOSIS OF PATIENTS WITH HYPERTENSIVE DYSCIRCULATORY ENCEPHALOPATHY AND CONCOMITANT HYPOTHYROIDISM IN POLYCLINIC CONDITIONS;Clinical and Preventive Medicine;2023-09-30

2. Superior stroke prevention with angiotensin receptor blockers compared with other antihypertensive drugs;Expert Opinion on Drug Safety;2023-02-01

3. Cerebrovascular recovery after stroke with individual and combined losartan and captopril treatment of SHRsp;Vascular Pharmacology;2017-09

4. Effectiveness and safety of valsartan/amlodipine in hypertensive patients with stroke;Medicine;2017-06

5. Endothelium as a target for new therapeutic strategies in cerebral vascular diseases;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2017